Literature DB >> 24014506

Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective.

Thomas G Kühl1, Sybille Dihanich, Andrew M S Wong, Jonathan D Cooper.   

Abstract

The neuronal ceroid lipofuscinoses (Batten disease) are collectively the most common inherited neurodegenerative disorder of childhood. Mouse models of neuronal ceroid lipofuscinosis represent a powerful resource for investigating the underlying disease mechanisms, which remain poorly understood. Here we present a new rostrocaudal analysis of regional brain volume rather than focusing on central nervous system structures that can be affected. This has revealed an earlier onset of regional atrophy than was suspected in infantile neuronal ceroid lipofuscinosis (or CLN1 disease, infantile), with a greater involvement of rostral structures. We have also provided the first description of regional atrophy in severely affected mice with the juvenile variant (CLN3 disease, juvenile). These data reveal new perspectives on how the central nervous system is affected in these disorders, which have implications for judging the efficacy of therapeutic strategies in preclinical studies.

Entities:  

Keywords:  neuronal ceroid lipofuscinosis; regional neurodegeneration; stereological measurement of brain volume

Mesh:

Substances:

Year:  2013        PMID: 24014506     DOI: 10.1177/0883073813494479

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  9 in total

1.  Synergistic effects of treating the spinal cord and brain in CLN1 disease.

Authors:  Charles Shyng; Hemanth R Nelvagal; Joshua T Dearborn; Jaana Tyynelä; Robert E Schmidt; Mark S Sands; Jonathan D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-03       Impact factor: 11.205

2.  Neurodegeneration and Epilepsy in a Zebrafish Model of CLN3 Disease (Batten Disease).

Authors:  Kim Wager; Anselm A Zdebik; Sonia Fu; Jonathan D Cooper; Robert J Harvey; Claire Russell
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

3.  Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures.

Authors:  Joshua T Dearborn; Hemanth R Nelvagal; Nicholas R Rensing; Keigo Takahashi; Stephanie M Hughes; Thomas M Wishart; Jonathan D Cooper; Michael Wong; Mark S Sands
Journal:  Sci Rep       Date:  2022-07-04       Impact factor: 4.996

4.  Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep.

Authors:  Hemanth R Nelvagal; Samantha L Eaton; Sophie H Wang; Elizabeth M Eultgen; Keigo Takahashi; Steven Q Le; Rachel Nesbitt; Joshua T Dearborn; Nicholas Siano; Ana C Puhl; Patricia I Dickson; Gerard Thompson; Fraser Murdoch; Paul M Brennan; Mark Gray; Stephen N Greenhalgh; Peter Tennant; Rachael Gregson; Eddie Clutton; James Nixon; Chris Proudfoot; Stefano Guido; Simon G Lillico; C Bruce A Whitelaw; Jui-Yun Lu; Sandra L Hofmann; Sean Ekins; Mark S Sands; Thomas M Wishart; Jonathan D Cooper
Journal:  J Clin Invest       Date:  2022-10-17       Impact factor: 19.456

5.  Evidence for aberrant astrocyte hemichannel activity in Juvenile Neuronal Ceroid Lipofuscinosis (JNCL).

Authors:  Maria Burkovetskaya; Nikolay Karpuk; Juan Xiong; Megan Bosch; Michael D Boska; Hideyuki Takeuchi; Akio Suzumura; Tammy Kielian
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

6.  Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography.

Authors:  Janos Groh; David Stadler; Mathias Buttmann; Rudolf Martini
Journal:  Acta Neuropathol Commun       Date:  2014-05-10       Impact factor: 7.801

7.  Proteomic mapping of differentially vulnerable pre-synaptic populations identifies regulators of neuronal stability in vivo.

Authors:  Maica Llavero Hurtado; Heidi R Fuller; Andrew M S Wong; Samantha L Eaton; Thomas H Gillingwater; Giuseppa Pennetta; Jonathan D Cooper; Thomas M Wishart
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

8.  Comparative proteomic profiling reveals mechanisms for early spinal cord vulnerability in CLN1 disease.

Authors:  Hemanth R Nelvagal; Maica Llavero Hurtado; Samantha L Eaton; Rachel A Kline; Douglas J Lamont; Mark S Sands; Thomas M Wishart; Jonathan D Cooper
Journal:  Sci Rep       Date:  2020-09-16       Impact factor: 4.379

9.  Spinal manifestations of CLN1 disease start during the early postnatal period.

Authors:  H R Nelvagal; J T Dearborn; J R Ostergaard; M S Sands; J D Cooper
Journal:  Neuropathol Appl Neurobiol       Date:  2020-09-07       Impact factor: 8.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.